Skip to main content
TipRanks
Go Ultimate75% OFF

Aspen Pharmacare (LDZU) Income Statement

1 Followers

Aspen Pharmacare Income Statement

Last quarter (Q4 2026), Aspen Pharmacare's total revenue was R18.40B, a decrease of 21.93% from the same quarter last year. In Q4, Aspen Pharmacare's net income was R1.21B. See Aspen Pharmacare’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementJun 26Jun 25Jun 24Jun 23Jun 22
R 34.14BR 43.36BR 44.71BR 40.71BR 38.61B
R 13.76BR 19.13BR 19.42BR 18.41BR 18.31B
R 8.48BR 17.69BR 12.42BR 11.05BR 9.63B
Depreciation and AmortizationR 1.88BR 2.09BR 1.97BR 1.79BR 1.71B
R 7.16BR 3.62BR 9.90BR 10.72BR 10.45B
R 5.29BR 1.44BR 7.00BR 7.82BR 8.67B
R -5.70BR -1.56BR -1.28BR -1.27BR -537.00M
R -409.30MR -123.00MR 5.71BR 6.55BR 8.13B
R 2.59BR -1.08BR 4.40BR 5.23BR 6.49B
Per Share Metrics
Basic EPSR 5.79R -2.44R 9.91R 11.77R 14.32
Diluted EPSR 5.79R -2.44R 9.91R 11.77R 14.32
Weighted Average Shares Outstanding444.10M444.20M444.20M444.20M453.00M
Weighted Average Shares Outstanding (Diluted)444.10M444.20M444.20M444.20M453.00M

Currency in ZAR

Aspen Pharmacare Earnings and Revenue History

-25B025B50B-10 %0 %10 %20 %EarningsProfit Margin2017201820192020202120222023202420252026RevenueEarningsProfit Margin